Dr. Lal Path Labs · NSE: LALPATHLAB · BSE: 539524
Q4 FY19 results · Jan–Mar 2019
Dr. Lal Path Labs reported revenue from operations of ₹301.10 crore and net profit of ₹47.40 crore for Q4 FY19 (Jan–Mar 2019), on a consolidated basis.
| Item | Q4 FY19 | Q4 FY18 | YoY | Q3 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 301.10 | — | — | 292.50 | +2.9% |
| Other income | 13.50 | — | — | 12.20 | +10.7% |
| Total income | 314.60 | — | — | 304.70 | +3.2% |
| Profit before tax | 69.20 | — | — | 67.90 | +1.9% |
| Net profit for the period | 47.40 | — | — | 46.10 | +2.8% |
| Attributable to shareholders of the company | 47.10 | — | — | 45.80 | +2.8% |
| EPS, basic (₹) | 5.72 | — | — | 5.56 | +2.9% |
| Net margin (%) | 15.7 | — | 15.8 |
| Item | Q4 FY19 | Q4 FY18 | YoY | Q3 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 292.00 | — | — | 282.80 | +3.3% |
| Other income | 13.00 | — | — | 11.90 | +9.2% |
| Total income | 305.00 | — | — | 294.70 | +3.5% |
| Profit before tax | 67.10 | — | — | 65.30 | +2.8% |
| Net profit for the period | 46.00 | — | — | 44.30 | +3.8% |
| EPS, basic (₹) | 5.59 | — | — | 5.38 | +3.9% |
| Net margin (%) | 15.8 | — | 15.7 |
Consolidated
- Filed with BSE
- 17 May 2019, 18:03 IST
- Board meeting
- 17 May 2019
- Period
- 01 Jan 2019 to 31 Mar 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 17 May 2019, 18:03 IST
- Board meeting
- 17 May 2019
- Period
- 01 Jan 2019 to 31 Mar 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE